These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 20731567)

  • 1. Development of new antibacterials: a laudable aim, but what is the value?
    Tillotson GS
    Clin Infect Dis; 2010 Sep; 51(6):752-3; author reply 754-5. PubMed ID: 20731567
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter in response to the Infectious Diseases Society of America's 10 x '20 Initiative.
    Burgess DS; Slain D; Mohr J; Wong-Beringer A; Destache C; Suda K
    Clin Infect Dis; 2010 Sep; 51(6):753; author reply 754-5. PubMed ID: 20731568
    [No Abstract]   [Full Text] [Related]  

  • 3. Questions about the 10 x '20 Initiative.
    Outterson K; Powers JH; Gould IM; Kesselheim AS
    Clin Infect Dis; 2010 Sep; 51(6):751-2; author reply 754-5. PubMed ID: 20731566
    [No Abstract]   [Full Text] [Related]  

  • 4. A call for antibiotic alternatives research.
    Stanton TB
    Trends Microbiol; 2013 Mar; 21(3):111-3. PubMed ID: 23473628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Addressing the frustrations of finding new effective antibacterials to combat drug resistant bacteria.
    Fernandes P; Pizza M
    Curr Opin Microbiol; 2008 Oct; 11(5):385-6. PubMed ID: 18804177
    [No Abstract]   [Full Text] [Related]  

  • 6. Antimicrobial resistance: no action today, no cure tomorrow.
    Sharma A
    Indian J Med Microbiol; 2011; 29(2):91-2. PubMed ID: 21654100
    [No Abstract]   [Full Text] [Related]  

  • 7. The 10 x '20 Initiative: pursuing a global commitment to develop 10 new antibacterial drugs by 2020.
    Infectious Diseases Society of America
    Clin Infect Dis; 2010 Apr; 50(8):1081-3. PubMed ID: 20214473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibacterial resistance: is there a way out of the woods?
    Marra A
    Future Microbiol; 2011 Jul; 6(7):707-9. PubMed ID: 21797683
    [No Abstract]   [Full Text] [Related]  

  • 9. Multi-targeting by monotherapeutic antibacterials.
    Silver LL
    Nat Rev Drug Discov; 2007 Jan; 6(1):41-55. PubMed ID: 17159922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antibiotics - quo vadit?].
    Lode HM; Stahlmann R
    Dtsch Med Wochenschr; 2012 Jun; 137(24):1314-6. PubMed ID: 22669701
    [No Abstract]   [Full Text] [Related]  

  • 11. Coping with antibiotic resistance: the impending crisis.
    Gould IM
    Int J Antimicrob Agents; 2010 Nov; 36 Suppl 3():S1-2. PubMed ID: 21129626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural products as a source of drug leads to overcome drug resistance.
    Silver LL
    Future Microbiol; 2015; 10(11):1711-8. PubMed ID: 26517443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial resistance and extinction.
    Desikan P
    Indian J Med Microbiol; 2011; 29(3):207-8. PubMed ID: 21860097
    [No Abstract]   [Full Text] [Related]  

  • 14. GAIN Act legislation: is it enough?
    Tillotson GS
    Lancet Infect Dis; 2012 Nov; 12(11):823-4. PubMed ID: 23099071
    [No Abstract]   [Full Text] [Related]  

  • 15. New antibiotic development hailed as game changing.
    Kirby T
    Lancet Infect Dis; 2015 Mar; 15(3):271-2. PubMed ID: 25749231
    [No Abstract]   [Full Text] [Related]  

  • 16. Overcoming the current deadlock in antibiotic research.
    Schäberle TF; Hack IM
    Trends Microbiol; 2014 Apr; 22(4):165-7. PubMed ID: 24698433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conclusions: the future of antimicrobial therapy - Augmentin and beyond.
    Ball P
    Int J Antimicrob Agents; 2007 Dec; 30 Suppl 2():S139-41. PubMed ID: 18029150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intra-abdominal infections: model of antibiotic stewardship in an era with limited antimicrobial options.
    Leone S; Stefani S; Venditti M; Grossi P; Colizza S; De Gasperi A; Scaglione F; Sganga G; Esposito S;
    Int J Antimicrob Agents; 2011 Sep; 38(3):271-2. PubMed ID: 21782394
    [No Abstract]   [Full Text] [Related]  

  • 19. The drug-resistant bacteria that pose the greatest health threats.
    Willyard C
    Nature; 2017 Feb; 543(7643):15. PubMed ID: 28252092
    [No Abstract]   [Full Text] [Related]  

  • 20. 2012 and beyond: potential for the start of a second pre-antibiotic era?
    Appelbaum PC
    J Antimicrob Chemother; 2012 Sep; 67(9):2062-8. PubMed ID: 22687888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.